The added value of laboratory markers to mortality risk scores in acute pulmonary embolism

J Crit Care. 2017 Aug:40:307. doi: 10.1016/j.jcrc.2017.04.034. Epub 2017 Apr 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Disease
  • Biomarkers*
  • Humans
  • Predictive Value of Tests
  • Prognosis
  • Pulmonary Embolism*
  • Risk
  • Risk Assessment

Substances

  • Biomarkers